The Heartline™ Study is a nationwide, randomized, controlled, app-based, virtual research study sponsored by Janssen Pharmaceuticals, Inc., a member of the Janssen Pharmaceutical Companies of Johnson & Johnson. “The Heartline™ Study will help further understanding of how our technology could both contribute to science and help improve health outcomes, including reducing the risk of stroke.” “Apple technology is making a meaningful impact on scientific research through the powerful capabilities of iPhone and Apple Watch, all with privacy at the center of the participant experience,” said Myoung Cha, Apple's Head of Health Strategic Initiatives. This approach to conducting a clinical trial, if successful, could potentially save time and cost. Through the app-based approach, the study will enable participants to engage in the study remotely, right from their iPhone and in some cases an Apple Watch, rather than travel to a clinical trial site.
0 Comments
Leave a Reply. |